ArticleCNS drugs2023

Long-Term Treatment Over 52 Weeks with Monthly Fremanezumab in Drug-Resistant Migraine: A Prospective Multicenter Cohort Study.

Valeria Caponnetto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.